Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Host Range and Population Survey of Spodoptera frugiperda Rhabdovirus.

Schroeder L, Mar TB, Haynes JR, Wang R, Wempe L, Goodin MM.

J Virol. 2019 Mar 5;93(6). pii: e02028-18. doi: 10.1128/JVI.02028-18. Print 2019 Mar 15.

PMID:
30626676
2.

Immunogenicity and specificity of norovirus Consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations.

Parra GI, Bok K, Taylor R, Haynes JR, Sosnovtsev SV, Richardson C, Green KY.

Vaccine. 2012 May 21;30(24):3580-6. doi: 10.1016/j.vaccine.2012.03.050. Epub 2012 Mar 31.

3.

Therapeutic DNA vaccine induces broad T cell responses in the gut and sustained protection from viral rebound and AIDS in SIV-infected rhesus macaques.

Fuller DH, Rajakumar P, Che JW, Narendran A, Nyaundi J, Michael H, Yager EJ, Stagnar C, Wahlberg B, Taber R, Haynes JR, Cook FC, Ertl P, Tite J, Amedee AM, Murphey-Corb M.

PLoS One. 2012;7(3):e33715. doi: 10.1371/journal.pone.0033715. Epub 2012 Mar 19.

4.

H1N1 influenza virus-like particles: physical degradation pathways and identification of stabilizers.

Kissmann J, Joshi SB, Haynes JR, Dokken L, Richardson C, Middaugh CR.

J Pharm Sci. 2011 Feb;100(2):634-45. doi: 10.1002/jps.22304.

PMID:
20669328
5.

Influenza virus-like particle vaccines.

Haynes JR.

Expert Rev Vaccines. 2009 Apr;8(4):435-45. doi: 10.1586/erv.09.8. Review.

PMID:
19348559
6.

Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge.

Haynes JR, Dokken L, Wiley JA, Cawthon AG, Bigger J, Harmsen AG, Richardson C.

Vaccine. 2009 Jan 22;27(4):530-41. doi: 10.1016/j.vaccine.2008.11.011. Epub 2008 Nov 19.

PMID:
19026705
7.

Potent protective cellular immune responses generated by a DNA vaccine encoding HSV-2 ICP27 and the E. coli heat labile enterotoxin.

Haynes JR, Arrington J, Dong L, Braun RP, Payne LG.

Vaccine. 2006 Jun 5;24(23):5016-26. Epub 2006 Mar 31.

PMID:
16621198
8.

DNA immunization in combination with effective antiretroviral drug therapy controls viral rebound and prevents simian AIDS after treatment is discontinued.

Fuller DH, Rajakumar PA, Wu MS, McMahon CW, Shipley T, Fuller JT, Bazmi A, Trichel AM, Allen TM, Mothe B, Haynes JR, Watkins DI, Murphey-Corb M.

Virology. 2006 Apr 25;348(1):200-15. Epub 2006 Jan 24.

9.

Epidermal DNA vaccine for influenza is immunogenic in humans.

Drape RJ, Macklin MD, Barr LJ, Jones S, Haynes JR, Dean HJ.

Vaccine. 2006 May 22;24(21):4475-81. Epub 2005 Aug 19.

PMID:
16150518
10.

Particle-mediated DNA vaccine delivery to the skin.

Haynes JR.

Expert Opin Biol Ther. 2004 Jun;4(6):889-900. Review.

PMID:
15174971
11.

Needle-free epidermal powder immunization.

Chen D, Maa YF, Haynes JR.

Expert Rev Vaccines. 2002 Oct;1(3):265-76. Review.

PMID:
12901567
12.

Particle-mediated DNA vaccination of mice, monkeys and men: looking beyond the dogma.

Payne LG, Fuller DH, Haynes JR.

Curr Opin Mol Ther. 2002 Oct;4(5):459-66. Review.

PMID:
12435047
13.

Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines.

Arrington J, Braun RP, Dong L, Fuller DH, Macklin MD, Umlauf SW, Wagner SJ, Wu MS, Payne LG, Haynes JR.

J Virol. 2002 May;76(9):4536-46.

14.

Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine.

Fuller DH, Rajakumar PA, Wilson LA, Trichel AM, Fuller JT, Shipley T, Wu MS, Weis K, Rinaldo CR, Haynes JR, Murphey-Corb M.

J Virol. 2002 Apr;76(7):3309-17.

15.

Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine.

Roy MJ, Wu MS, Barr LJ, Fuller JT, Tussey LG, Speller S, Culp J, Burkholder JK, Swain WF, Dixon RM, Widera G, Vessey R, King A, Ogg G, Gallimore A, Haynes JR, Heydenburg Fuller D.

Vaccine. 2000 Nov 22;19(7-8):764-78.

PMID:
11115698
16.

Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates.

McCluskie MJ, Brazolot Millan CL, Gramzinski RA, Robinson HL, Santoro JC, Fuller JT, Widera G, Haynes JR, Purcell RH, Davis HL.

Mol Med. 1999 May;5(5):287-300.

17.

Genetic vaccines.

Haynes JR.

Infect Dis Clin North Am. 1999 Mar;13(1):11-26, v. Review.

PMID:
10198789
18.

Immunization of dogs and cats with a DNA vaccine against rabies virus.

Osorio JE, Tomlinson CC, Frank RS, Haanes EJ, Rushlow K, Haynes JR, Stinchcomb DT.

Vaccine. 1999 Mar 5;17(9-10):1109-16.

PMID:
10195621
19.

Gene gun-based nucleic acid immunization alone or in combination with recombinant vaccinia vectors suppresses virus burden in rhesus macaques challenged with a heterologous SIV.

Fuller DH, Simpson L, Cole KS, Clements JE, Panicali DL, Montelaro RC, Murphey-Corb M, Haynes JR.

Immunol Cell Biol. 1997 Aug;75(4):389-96.

PMID:
9315483
20.

Manipulation of HIV-1 gp120-specific immune responses elicited via gene gun-based DNA immunization.

Prayaga SK, Ford MJ, Haynes JR.

Vaccine. 1997 Aug-Sep;15(12-13):1349-52.

PMID:
9302743
21.

Enhancement of immunodeficiency virus-specific immune responses in DNA-immunized rhesus macaques.

Fuller DH, Corb MM, Barnett S, Steimer K, Haynes JR.

Vaccine. 1997 Jun;15(8):924-6.

PMID:
9234549
22.

Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit.

Barnett SW, Rajasekar S, Legg H, Doe B, Fuller DH, Haynes JR, Walker CM, Steimer KS.

Vaccine. 1997 Jun;15(8):869-73.

PMID:
9234536
23.

Cross-protection among lethal H5N2 influenza viruses induced by DNA vaccine to the hemagglutinin.

Kodihalli S, Haynes JR, Robinson HL, Webster RG.

J Virol. 1997 May;71(5):3391-6.

25.

Induction of immunodeficiency virus-specific immune responses in rhesus monkeys following gene gun-mediated DNA vaccination.

Fuller DH, Murphey-Corb M, Clements J, Barnett S, Haynes JR.

J Med Primatol. 1996 Jun;25(3):236-41.

PMID:
8892045
26.

Simian immunodeficiency virus DNA vaccine trial in macaques.

Lu S, Arthos J, Montefiori DC, Yasutomi Y, Manson K, Mustafa F, Johnson E, Santoro JC, Wissink J, Mullins JI, Haynes JR, Letvin NL, Wyand M, Robinson HL.

J Virol. 1996 Jun;70(6):3978-91.

27.

DNA vaccines.

Robinson HL, Lu S, Feltquate DM, Torres CT, Richmond J, Boyle CM, Morin MJ, Santoro JC, Webster RG, Montefiori D, Yasutomi Y, Letvin NL, Manson K, Wyand M, Haynes JR.

AIDS Res Hum Retroviruses. 1996 Mar 20;12(5):455-7. Review. No abstract available.

PMID:
8962755
28.

Particle-mediated nucleic acid immunization.

Haynes JR, McCabe DE, Swain WF, Widera G, Fuller JT.

J Biotechnol. 1996 Jan 26;44(1-3):37-42. Review.

PMID:
8717384
29.

Immune responses to hepatitis B virus surface and core antigens in mice, monkeys, and pigs after Accell particle-mediated DNA immunization.

Fuller JT, Fuller DH, McCabe D, Haynes JR, Widera G.

Ann N Y Acad Sci. 1995 Nov 27;772:282-4. No abstract available.

PMID:
8546409
30.

Use of DNAs expressing HIV-1 Env and noninfectious HIV-1 particles to raise antibody responses in mice.

Lu S, Santoro JC, Fuller DH, Haynes JR, Robinson HL.

Virology. 1995 May 10;209(1):147-54.

31.

DNA vaccines: a novel approach to immunization.

Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL.

Int J Immunopharmacol. 1995 Feb;17(2):79-83. Review.

PMID:
7657410
32.
34.

Accell particle-mediated DNA immunization elicits humoral, cytotoxic, and protective immune responses.

Haynes JR, Fuller DH, Eisenbraun MD, Ford MJ, Pertmer TM.

AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S43-5.

PMID:
7865332
35.

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations.

Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL.

Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11478-82.

36.
38.

Cloning and characterization of ribosomal RNA genes from Opisthorchis viverrini.

Korbsrisate S, Mongkolsuk S, Haynes JR, Wong Q, Sirisinha S.

Parasitology. 1992 Apr;104 ( Pt 2):323-9.

PMID:
1594296
39.

Nucleotide sequence of the small subunit ribosomal RNA-encoding gene from Opisthorchis viverrini.

Korbsrisate S, Mongkolsuk S, Haynes JR, England D, Sirisinha S.

Gene. 1991 Sep 15;105(2):259-61.

PMID:
1937023
40.

Strategy for developing a genetically-engineered whole-virus vaccine against HIV.

Haynes JR, Yao FL, Ma J, Cao SX, Klein MH.

Mol Immunol. 1991 Mar;28(3):231-4.

PMID:
2017194
41.

Production of immunogenic HIV-1 viruslike particles in stably engineered monkey cell lines.

Haynes JR, Cao SX, Rovinski B, Sia C, James O, Dekaban GA, Klein MH.

AIDS Res Hum Retroviruses. 1991 Jan;7(1):17-27.

PMID:
1707639
43.
44.

Construct validity of the Kendrick Battery with institutionalized aged.

Fish M, Hayslip B Jr, Marcus S, Haynes JR.

J Psychol. 1986 Jul;120(4):335-43.

PMID:
3761219
45.

Structural relationship of human interferon alpha genes and pseudogenes.

Henco K, Brosius J, Fujisawa A, Fujisawa JI, Haynes JR, Hochstadt J, Kovacic T, Pasek M, Schamböck A, Schmid J, et al.

J Mol Biol. 1985 Sep 20;185(2):227-60.

PMID:
4057246
46.
47.

Transcription of the beta-like globin genes and pseudogenes of the goat in a cell-free system.

Luse DS, Haynes JR, VanLeeuwen D, Schon EA, Cleary ML, Shapiro SG, Lingrel JB, Roeder RG.

Nucleic Acids Res. 1981 Sep 11;9(17):4339-54.

48.
49.

Identification by nucleotide sequence analysis of a goat pseudoglobin gene.

Cleary ML, Haynes JR, Schon EA, Lingrel JB.

Nucleic Acids Res. 1980 Oct 24;8(20):4791-802.

50.

The isolation of the beta A-, beta C-, and gamma-globin genes and a presumptive embryonic globin gene from a goat DNA recombinant library.

Haynes JR, Rosteck P Jr, Schon EA, Gallagher PM, Burks DJ, Smith K, Lingrel JB.

J Biol Chem. 1980 Jul 10;255(13):6355-67.

Supplemental Content

Loading ...
Support Center